## Steroid priming does not potentiate the effect of IFN-a. The comparative efficacy of prednisolone followed by (HEPATOLOGY 1996;23:700-707.) interferon alfa (IFN-a) versus IFN-a alone in enhancing the rate of antibody to hepatitis B e antigen (anti-HBe) seroconversion has not been evaluated in a
β¦ LIBER β¦
Dual-centre, double-blind, randomised trial of lymphoblastoid interferon alpha with or without steroid pretreatment in children with chronic hepatitis B
β Scribed by R. Giacchino; J. Main; A. Timitilli; G. Giambartolomei; F. Facco; C. Cirillo; M. R. Jacyna; M. G. Brook; F. Callea; P. Kariayannis; A. Terragna; H. C. Thomas
- Book ID
- 114796940
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 404 KB
- Volume
- 15
- Category
- Article
- ISSN
- 0106-9543
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Lymphoblastoid interferon alfa with or w
β
G V Gregorio; P Jara; L Hierro; C Diaz; A de la Vega; A Vegnente; R Iorio; F Bor
π
Article
π
1996
π
John Wiley and Sons
π
English
β 202 KB
π 1 views
Lymphoblastoid interferon alfa with or w
β
GV Gregorio; P Jara; L Hierro; C Diaz; A de la Vega; A Vegnente; R Iorio; F Bort
π
Article
π
1996
π
John Wiley and Sons
π
English
β 206 KB
Randomised, double-blind, placebo-contro
β
Olle Reichard; Gunnar Norkrans; Aril FrydΓ©n; Jean-Henrik Braconier; Anders SΓΆnne
π
Article
π
1998
π
The Lancet
π
English
β 77 KB
A randomized, double-blind, placebo-cont
β
K. Meijer; E. B. Haagsma; J. Van Der Meer; for the CHARIBDIS Study Group
π
Article
π
2004
π
John Wiley and Sons
π
English
β 216 KB
P.279 A randomised trial of pegylated in
β
A. Ciancio; A. Picciotto; C. Giordanino; A. Smedile; M. Tabone; A. Manca; G. Mar
π
Article
π
2006
π
Elsevier Science
π
English
β 138 KB
Final results of a double-blind, placebo
β
Paul J. Pockros; Lennox Jeffers; Nezam Afdhal; Zachary D. Goodman; David Nelson;
π
Article
π
2007
π
John Wiley and Sons
π
English
β 383 KB
π 2 views
## Interferon-β₯1b (IFN-β₯1b ) is a pleiotropic cytokine that displays antifibrotic, antiviral, and antiproliferative activity. A total of 502 patients with compensated liver disease and an Ishak fibrosis score of 4-6 were randomized in a double-blind, placebo-controlled study, and 488 of these pati